Miura K, Yasuda K, Yanase T et al. (1996). “Mutation of cytochrome P-45017 alpha gene (CYP17) in a Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism: with a review of Japanese patients with mutations of CYP17”. J. Clin. Endocrinol. Metab.81 (10): 3797–801. doi:10.1210/jc.81.10.3797. PMID8855840.
Miller WL, Geller DH, Auchus RJ (1999). “The molecular basis of isolated 17,20 lyase deficiency”. Endocr. Res.24 (3–4): 817–25. doi:10.3109/07435809809032692. PMID9888582.
Strauss JF (2004). “Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome”. Annals of the New York Academy of Sciences997: 42–8. doi:10.1196/annals.1290.005. PMID14644808.
Haider S, Patel J, Poojari C, Neidle S (2010). “Molecular modeling on inhibitor complexes and active-site dynamics of cytochrome P450 C17, a target for prostate cancer therapy”. J. Mol Biol400 (5): 1078–098. doi:10.1016/j.jmb.2010.05.069. PMID20595043.